259 related articles for article (PubMed ID: 23999423)
1. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.
Heliövaara-Peippo S; Hurskainen R; Teperi J; Aalto AM; Grénman S; Halmesmäki K; Jokela M; Kivelä A; Tomás E; Tuppurainen M; Paavonen J
Am J Obstet Gynecol; 2013 Dec; 209(6):535.e1-535.e14. PubMed ID: 23999423
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
JAMA; 2004 Mar; 291(12):1456-63. PubMed ID: 15039412
[TBL] [Abstract][Full Text] [Related]
3. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Vuorma S; Yliskoski M; Paavonen J
Acta Obstet Gynecol Scand; 2009; 88(12):1389-96. PubMed ID: 19878089
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.
Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
Lancet; 2001 Jan; 357(9252):273-7. PubMed ID: 11214131
[TBL] [Abstract][Full Text] [Related]
5. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial.
Leminen H; Heliövaara-Peippo S; Halmesmäki K; Teperi J; Grenman S; Kivelä A; Tuppurainen M; Paavonen J; Hurskainen R
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):318-25. PubMed ID: 22168810
[TBL] [Abstract][Full Text] [Related]
6. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
Milsom I
Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
[TBL] [Abstract][Full Text] [Related]
7. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial.
Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Tomas E; Tuppurainen M; Paavonen J
BJOG; 2010 Apr; 117(5):602-9. PubMed ID: 20156209
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of the levonorgestrel-releasing intrauterine system.
Inki P
Contraception; 2007 Jun; 75(6 Suppl):S161-6. PubMed ID: 17531611
[TBL] [Abstract][Full Text] [Related]
12. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
[TBL] [Abstract][Full Text] [Related]
13. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
[TBL] [Abstract][Full Text] [Related]
15. Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.
Kaunitz AM; Stern L; Doyle J; Etschmaie MR
Manag Care Interface; 2007 Mar; 20(3):47-50. PubMed ID: 17458481
[TBL] [Abstract][Full Text] [Related]
16. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
[TBL] [Abstract][Full Text] [Related]
17. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.
Silva-Filho AL; Pereira Fde A; de Souza SS; Loures LF; Rocha AP; Valadares CN; Carneiro MM; Tavares RL; Camargos AF
Contraception; 2013 Apr; 87(4):409-15. PubMed ID: 23228505
[TBL] [Abstract][Full Text] [Related]
18. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of quality of life and cost-effectiveness of definitive surgery and the levonorgestrel intrauterine system as treatment options for heavy menstrual bleeding.
Adigüzel C; Seyfettinoğlu S; Aka Satar D; Arlier S; Eskimez E; Kaya F; Nazik H
Turk J Med Sci; 2017 Jun; 47(3):789-794. PubMed ID: 28618723
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
